Concepedia

Arlene Taylor

AT

Statistics

Publications

11

Citations

2K

H-Index

11

Active since

1993

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Alfred I. duPont Hospital for Children

Universitair Ziekenhuis Leuven

The University of Texas Health Science Center at San Antonio

Arlene Taylor is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacotherapy, and pediatrics.

Top concepts

Publications per year

1993–2015

11

Publications

11

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

J. Maertens, Issam Raad, G. Petrikkos et al. · Clinical Infectious Diseases · 2004 · 659 citations · Full text

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study

Bernardo L. Rapoport, Karin Jordan, Judith A. Boice et al. · Supportive Care in Cancer · 2009 · 233 citations

, , +9

Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE

Steven M. Grunberg, Daniel T. T. Chua, Anish Maru et al. · Journal of Clinical Oncology · 2011 · 219 citations · Full text

Establishing the dose of the oral NK<sub>1</sub> antagonist aprepitant for the prevention of chemotherapy‐induced nausea and vomiting

Sant P. Chawla, Steven M. Grunberg, Richard J. Gralla et al. · Cancer · 2003 · 216 citations · Full text

Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis

Johan Maertens, Axel Glasmacher, Raoul Herbrecht et al. · Cancer · 2006 · 211 citations · Full text

1–5 of 11